TMOD3
Tropomodulin-3
Also known as: TMOD3_HUMAN, UTMOD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NYL9
- Gene
- TMOD3
- Ensembl
- ENSG00000138594
- Chromosome
- 15
- Canonical length
- 352 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Actin filaments,Cytosol
OverviewNCBI Gene
Enables cadherin binding activity involved in cell-cell adhesion. Predicted to be involved in actin filament organization; muscle contraction; and myofibril assembly. Predicted to act upstream of or within actin cytoskeleton organization; erythrocyte development; and positive regulation of mitotic cell cycle phase transition. Located in adherens junction. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
352 residues, UniProt reviewed canonical sequence.
>Q9NYL9|TMOD3
1 MALPFRKDLE KYKDLDEDEL LGNLSETELK QLETVLDDLD PENALLPAGF RQKNQTSKST
61 TGPFDREHLL SYLEKEALEH KDREDYVPYT GEKKGKIFIP KQKPVQTFTE EKVSLDPELE
121 EALTSASDTE LCDLAAILGM HNLITNTKFC NIMGSSNGVD QEHFSNVVKG EKILPVFDEP
181 PNPTNVEESL KRTKENDAHL VEVNLNNIKN IPIPTLKDFA KALETNTHVK CFSLAATRSN
241 DPVATAFAEM LKVNKTLKSL NVESNFITGV GILALIDALR DNETLAELKI DNQRQQLGTA
301 VELEMAKMLE ENTNILKFGY QFTQQGPRTR AANAITKNND LVRKRRVEGD HQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMOD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 41 nTPM
- placenta: 21 nTPM
- lung: 21 nTPM
- tonsil: 18 nTPM
- vagina: 18 nTPM
- stomach: 16 nTPM
Single-cell type
- esophageal apical cells: 1,943 nCPM
- alveolar cells type 1: 724 nCPM
- mast cells: 518 nCPM
- neutrophils: 518 nCPM
- ocular epithelial cells: 506 nCPM
- neutrophil progenitors: 462 nCPM
Immune cell
- basophil: 48 nTPM
- neutrophil: 46 nTPM
- eosinophil: 42 nTPM
- non-classical monocyte: 40 nTPM
- intermediate monocyte: 35 nTPM
- plasmacytoid DC: 29 nTPM
Brain region
- choroid plexus: 18 nTPM
- thalamus: 16 nTPM
- midbrain: 15 nTPM
- medulla oblongata: 14 nTPM
- spinal cord: 14 nTPM
- amygdala: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- erythrocyte development
- mitotic cell cycle phase transition
- muscle contraction
- myofibril assembly
- pointed-end actin filament capping
- positive regulation of mitotic cell cycle phase transition
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMOD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMOD3 as an antibody target. Whether an autoantibody or antibody against TMOD3 could matter depends on whether native TMOD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMOD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMOD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...